Identification of a novel <i>PLS1</i> heterozygous variant causing autosomal dominant non‑syndromic hearing loss
Congenital disabling hearing impairment is a prevalent sensory deficit, affecting >30,000 newborns annually in China. Non-syndromic hearing loss (NSHL) accounts for a notable proportion of these cases, ~60% of which are attributed to genetic defects by heterogeneity. Although >120 genes have been linked to NSHL, a definitive molecular diagnosis remains elusive for approximately one-half of the individuals undergoing genetic testing. In the present study, a Chinese family with NSHL was investigated using next-generation sequencing of the affected members, with validation by Sanger sequencing. A novel variant was identified, namely plastin-1 (<i>PLS1</i>) c.981+5G>A. Functional analysis by reverse transcription PCR revealed that this variant induces exon skipping, establishing its pathogenic mechanism. <i>PLS1</i> encodes the actin-bundling protein plastin-1, which is highly abundant in the stereocilia of hair cells. Recent studies have implicated <i>PLS1</i> in hearing loss; therefore, the present study provides direct functional validation of its pathogenicity, expanding the pathogenic variation spectrum of <i>PLS1</i> and offering valuable insights into clinical diagnostic advancements and prenatal screening.
Authors
- Yao Xiong (ORCID: https://orcid.org/0000-0002-4169-4040)
- Chenxi Yang
- Dongyang Wang
- Juanzi Shi
Institutions
- Northwest Women's and Children's Hospital (CN)
Publication Details
- Journal
- Experimental and Therapeutic Medicine
- Published
- 2026-02-12
- DOI
- https://doi.org/10.3892/etm.2026.13105
- Primary Topic
- Genomics and Rare Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00